News

Sickle Cell Symposium: State of Sickle Cell Care in Massachusetts – The Way ForwardThe Massachusetts Sickle Cell Association, in partnership with the Town…

Gene-editing breakthroughs are bringing curative therapies closer to reality. The challenge now is ensuring African health systems are ready to deliver them. At the…

Etavopivat is a new medicine under development for treating blood disorders like sickle cell disease and thalassaemia. Sickle cell disease and thalassaemia are…

Historically, sickle cell disease (SCD) has been overshadowed by progress in other hematologic disorders, but recent advances are reshaping its clinical and…

Sickle cell disease is a genetic red blood cell disorder, affecting millions of people globally. This Seminar provides a comprehensive update on the disease,…

A novel patient-reported outcome tool designed to capture home-managed sickle cell pain crises (SCPC) demonstrated strong content validity in adolescents and adults…

Adults with sickle cell disease (SCD) face a substantial risk of stroke, most often in their 30s and 40s, with lasting physical disability and cognitive impairment…